Long-term effects of Helicobacter pylori infection on acid and pepsin secretion. by Halter, F. & Zetterman, R. K.
YALE JOURNAL OF BIOLOGY AND MEDICINE 69 (1996), pp. 99-104.
Copyright © 1996. All rights reserved.
Long-term Effects ofHelicobacterpylon
Infection onAcid and Pepsin Secretion
F. Haltera and R.K. Zettermanb
aDepartment. ofInternal Medicine, University Hospital, Inselspital, Bern, Switzerland and
bDepartmnent ofInternal Medicine, University ofNebraska Medical Center, Omaha, Nebraska
(Received March 8, 1996; accepted June 14, 1996)
Chronic Helicobacter pylori infection causes a slight postprandial hyper-
gastinemia, generally referred to asexaggerated orinappropriate gastrin release.
This can be ablated by eradication ofthis infective agent. The expectations that
this would further unravel the mysteries ofthe pathogenesis ofpeptic ulcerdis-
ease have not been fulfilled. It is now well established that ofconventional acid
secretory patterns such as basal acid secretion, maximum gastrin-stimulated
acid secretion, and ofsensitivity ofthe parietal cell to gastrin, only basal acid is
modified by chronic H. pylori colonization. This particularly relates to basal
secretion in duodenal ulcer patients, as basal secretion of otherwise healthy,
chronically H. pylori-infected subjects appears to be affected in only a small
proportion ofsubjects. It is ofparticular interest, however, thatchronic H. pylori
infection supplies a solid explanation why acid inhibitory pathways are defi-
cient in duodenal ulcerdisease, since this is reversible following H. pylori erad-
ication as demonstrated by elegant studies with gastrin-releasing, peptide-stim-
ulated acid secretion. Furthermore, it has gradually become apparent that exag-
gerated gastrin response is probably no more than an innocent bystander of
chronic H.pylori infection. Paradoxically, in a small subset ofpatients, hypo-or
anacidity accompanying chronc H. pylori infection can be reverted by H. pylori
eradication, for currently unknown reasons.
The question remains open whether enhanced pepsin release from the chiefcell,
which characterizes duodenal ulcer disease and is also reversible following H.
pylori eradication, has any direct implication in ulcer expression in duodenal
ulcer patients.
INTRODUCTION
The aim of this paper is to review current knowledge of the effect that chronic
Helicobacterpylori (HP)c infection exerts on chief and parietal cells with comparison to
the respective acute effects as extensively reviewed by Cave in this issue (Page 91).
Attempts are made toreconcile thesefindings with long-established changes in pepsin and
acid secretion ofpatients suffering from chronic peptic ulcer disease.
Cave has well demonstrated and elucidated the mechanisms involved through which
HP effector molecules induce in vitro effects on parietal and chiefcells. His observations
on increased pepsin release from thechiefcell ofisolated gastric glands ofrabbits can eas-
ily be reconciled with the previously established fact that in a substantial proportion of
duodenal ulcer (DU) patients, pepsinogen levels are elevated in the blood. This has long
been considered a pathognomonic marker of DU disease [1, 2]. Since it has also been
shown that this phenomenon is reversible following HP eradication [3], the causative rela-
tionship to HP infection is well established.
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It is considerably more difficult, however, to reconcile the in vitm findings obtained
in the parietal cells with the acid secretory pattern found in patients suffering from chron-
ic peptic ulcer disease or in otherwise healthy subjects who are chronically infected with
HP. The observation that acute HP infection blocks acid secretion in vivo can explain the
temporary hypo- or achlorhydria found in subjects who volunteered to be infected or in
those subjects who were accidentally infected with HP [4-6]. It also supplies a putative
explanation for observations made long before the pathogenic role ofHP was established,
that histamine or gastrin-resistant achlorhydria can occasionally occur in young people in
the absence ofatrophic gastritis [7]. The hypo- or achlorhydria observed following acute
HP infection must generally, however, be a temporary phenomenon since peptic ulcer dis-
ease is largely associated with normal or increased gastric acid production despite wide-
spread and undisputed association with HP infection. The molecular mechanisms through
which the parietal cells overcome the property of the potential HP effector molecule to
block acid secretion remains unknown. Furthermore, it is not established whether the acid
secretory capacity of the individual cell returns to preinfection values or whether up or
down regulation may occur in some subjects.
The association between peptic ulcer disease and gastric acid has been well recog-
nized since Schwarz [8] established the dictum "no acid, no ulcer." This fundamental
recognition has, however, provoked awidespread overestimation ofthe pathogenic role of
gastric acid and led to an erroneous belief that all peptic ulcer patients produce acid in
excess. Soon after the introduction of the maximum acid secretion test, which allows
quantitative assessment of acid production under standardized conditions, it was estab-
lished that this generalization was not appropriate. While DU patients on average secrete
more acid than healthy controls, this only holds true for a small proportion ofpatients suf-
fering from gastric ulcer, mainly those with prepyloric ulcers. A substantial proportion of
patients with gastric ulcers produce even less acid than healthy subjects. Even in DU dis-
ease, the overlap with acid secretory patterns of healthy subjects is considerable, as only
one-third of DU patients have a maximum acid output above those values observed in
healthy controls [9]. Another often overestimated abnormality of DU-associated acid
secretion is the increased sensitivity ofthe parietal cell to gastrin [10], which again affects
only a fraction of DU patients [11].
It is well-known that the maximum acid secretory capacity ofthe stomach correlates
with the number of parietal cells present in the corpus mucosa [12] and that, on average,
DU patients have a two-fold increase in the total parietal cell mass [13]. However, it has
also been recognized that gastritis is very widespread in peptic ulcer disease and can vary
from mild forms of superficial gastritis to more severe forms. The antrum is generally
affected, but extension to the gastric corpus may eventually lead to partial replacement of
parietal cells by mucous-secreting cells. Atrophic gastritis within the corpus mucosa has
been found to be particularly associated with ulcers in the upper part of the gastric fun-
dus. In this connection, the term pyloro-cardiac extension ofgastritis was created and duo-
deno-gastric reflux was considered by many as the causative factor for both chronic gas-
tritis and gastric ulcer [14].
Soon after it became possible to reliably measure plasma gastrin levels by radio-
immunoassay, it also became apparent that patients with gastric, and, to a lesser degree,
those with duodenal ulcer disease, had slightly increased gastrin levels, especially in the
postprandial phase. This so-called exaggerated or inappropriate gastrin release was
explained by a defect in the feedback loop through which gastrin release was inhibited
once the antral pH fell below 2.5 [15].
With the known trophic effect of gastrin, it was tempting to attribute the increase of
the parietal cell mass observed in DU patients to the growth-promoting effect of gastrin.
This hypothesis was indirectly supported by the observation that the vastmajority ofulcerHalterandZetterman: Effects ofH. pylori on acidandpepsin secretion
patients are infected with HP and that the inflammatory changes are largely reversible by
HPeradication [17]. This was considered by many to suggest that the disregulation ofgas-
trin release may be causally related to ulcer-associated hypersecretion of acid. The large
variation of the acid secretory patterns within ulcer patient populations, however, makes
it very unlikely that one simple variant such as a relatively modest increase in postpran-
dial gastrin would be the causative agent for ulcer associated changes in acid regulation.
DOES CHRONIC HP INFECTION CAUSE ACID HYPERSECRETION?
Though a large number ofstudies are available on this subject, the results are contro-
versial [18-29]. Unfortunately, the majority of reported studies provide only cross-sec-
tional data in small numbers of subjects, and some are based on retrospective data. The
availability ofefficacious regimens to eradicate HP infection has been particularly helpful
in elucidating how this infection modifies acid secretion in chronically infected subjects.
Important information has also been gained by comparing acid secretion between healthy
HP-positive and negative subjects.
Chronic HP infection and basal acid secretion
While the majority of studies indicate there are no differences in basal acid output
between HP-positive and negative subjects [18-25], a moderate increase ofbasal acid out-
put in HP-infected subjects was found in studies ofMullin et al. [26], Moss et al. [27], El-
Omar et al. [28], and Levi et al. [29]. The obvious reason for this discrepancy lies in the
particularly large individual variation of basal acid secretion. This can be more clearly
inferred from the well-designed, longitudinal study by the McColl group [28] where indi-
vidual values are displayed. Basal acid output was moderately elevated in HP-positive
subjects not affected by peptic ulcer disease, although more than 60 percent had values
overlapping that of HP-negative controls. It is of particular interest that HP eradication
failed to significantly reduce basal acid secretion in the HP-positive group. In their HP-
positive DU patients, basal acid secretion was higher than that observed in HP-positive
andHP-negative healthy controls, and the overlap with that ofboth control groups was rel-
atively small. Following HPeradication, values gradually fell reaching the level ofthe HP-
negative controls by the end of the one-year observation period. This indicates there is a
considerable lag to the very early ablation of the exaggerated gastrin release. Thus, it
appears that chronic HP infection enhances basal acid secretion in only a small proportion
ofotherwise healthy subjects, although it is responsible for the increased basal acid secre-
tion of a large fraction of HP-positive DU patients. Doubts prevail, however, as to what
degree this anomaly contributes to the expression ofulcer disease in the individual chron-
ically HP-infected subject.
Chronic HP infection and maximum gastrin-stimulated acid secretion
With the exception ofthe study ofLevi et al. [29], studies performed on both healthy
HP-positive subjects and on those affected by DU have not found that HP colonization
increases maximum acid output as induced by gastrin. It is of particular interest that HP
eradication fails to lower maximum acid output [18-28] even one year after eradication,
despite a much earlier ablation of the exaggerated gastrin release [28]. Similarly, neither
maximum acid output nor ED50 values, as determined in gastrin dose-response studies,
differed between HP-positive and negative subjects [23-25, 27]. Therefore, it appears very
unlikely that the increased parietal cell mass in DU disease is related to HP-mediated,
exaggerated gastrin release and that genetic reasons are a more likely, albeit speculative,
explanation.
Of particular interest is that the McColl group [30] recently reported that HP eradi-
cation leads to an increase in maximum acid output in a small subset of non-DU patients
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where chronic HP gastritis had been accompanied by profound hypochlorhydria or even
achlorhydria, thus mimicking the situation previously only encountered in patients with
acute HP infection. This observation demonstrates that chronic HP infection can exert
divergent effects in acid secretion in chronically infected patients, whereby no change or
an increase in secretory capacity is considerably more common than a decrease. It has
been speculated that different bacterial strains or genetic or other environmental influ-
ences might be responsible for this divergence [30].
Chronic HP infection and histamine-stimulated acid secretion
Findings obtained with maximum gastrin stimulation and studies performed with
maximum doses ofhistamine interestingly revealed a lower maximum acid output in HP-
positive than HP-negative DU patients [31]. The data are difficult to interpret and have
been criticized because of the unusually low HP prevalence in the DU patients of that
study [32], and a selection bias cannot be fully excluded. This observation, nevertheless,
further substantiates the hypothesis that chronic HP colonization reduces maximum acid
secretory capacity in a subset ofpatients.
DOES CHRONIC HP INFECTION INTERFERE WITH PHYSIOLOGIC
DOWN-REGULATION OFACID SECRETION?
Chronic HP infection and acidsecretion as stimulatedby the gastrin-releasingpeptide
New light into the puzzle ofchanges in the regulation ofacid secretion as induced by
chronic HP infection has come recently from observations that maximum GRP-stimulated
acid output is substantially higher in HP-positive subjects. In the only longitudinal study,
El-Omar et al. [28] found a three-fold increase in GRP-induced maximum acid output in
HP-positive, healthy subjects and a six-fold increase in DU patients. In both HP-positive
healthy subjects and DU patients, this increase was fully reversible following HP eradica-
tion. GRP has a considerably more complex function within the gastointestinal tract than
can be inferred from its name. In addition to being a potent stimulant ofgastrin release, it
simultaneously activates neuroendocrine pathways that exert inhibitory control on gastric
secretion. This is achieved by stimulation ofmultiple peptides (including cholecystokinin,
secretin, gastric-inhibitory peptide, vasoactive intestinal polypeptide, neurotensin and
enteroglucagon) [33-36]. These peptides exert their inhibitory influence by stimulating
release ofthe inhibitory peptide, somatostatin, from D cells within the antral and oxyntic
mucosa. GRP thus activates both stimulatory and inhibitory pathways of acid secretion.
Several studies have shown reduced somatostatin concentrations and messenger RNA
expression in the gastric mucosa of subjects with HP infection, a finding consistent with
disruption ofinhibitory control at this level [37-39]. Due to stimulation ofinhibitory path-
ways, maximum GRP-induced acid output is considerably smaller than that achieved with
gastrin. In HP-colonized subjects, this difference is much smaller than in healthy controls,
supporting the hypothesis of a defect in the inhibitory pathway. In DU patients, GRP-
induced maximum acid output is reduced towards values observed in healthy HP-negative
subjects within one year of HP eradication. Also, the increase in GRP-stimulated maxi-
mum acid secretion cannot be fully explained by the exaggerated gastrin release ofchron-
ically HP-infected subjects, since the HP-induced, exaggerated gastrin response resolved
much earlier than the increase in GRP-induced acid secretion [28].
SUMMARY
It has gradually become apparent that chronic HP infection may be responsible for
the increase in basal secretion observed in a relatively small fraction of HP-positive,
healthy subjects and that it may be causative for the increase in basal secretion present inHalter andZetterman: Effects ofH. pylori on acidandpepsin secretion 103
a substantial fraction of patients affected with DU disease. Changes in basal secretion,
however, do not appear to be mediated by the exaggerated gastrin release that character-
izes chronic HP infection. Similarly, chronic HP infection cannot be made responsible for
the increased maximum acid output ofDU patients nor does it supply an explanation for
the increased parietal cell mass observed in a substantial fraction of DU patients. In a
small subset of chronically HP-infected patients, maximum acid has even been found to
be reversibly decreased. There is no indication that chronic HP infection can be held
responsible for the increase in gastrin sensitivity ofthe parietal cell observed in some DU
patients. All these observations suggest that the exaggerated gastrin response resulting
from chronic HP colonization represents no more than an innocent epiphenomenon.
The known defect in acid inhibitory pathway in DU disease seems, however, to be a
direct consequence of chronic HP infection. The current knowledge of HP-induced
changes in acid secretion does not help to identify patients who are at particular risk to
develop peptic ulcer disease.
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